(Q43056110)

13 November 2017

title

Higher dopamine transporter density in Parkinson's disease patients with depression (English)

1 reference

13 November 2017

0 references

1 reference

11

1 reference

13 November 2017

Henrique B Ferraz

10

0 references

author name string

Andre C Felicio

1

1 reference

13 November 2017

Tais S Moriyama

2

1 reference

13 November 2017

Clecio Godeiro-Junior

3

1 reference

13 November 2017

Ming C Shih

4

1 reference

13 November 2017

Marcelo Q Hoexter

5

1 reference

13 November 2017

Vanderci Borges

6

1 reference

13 November 2017

Sonia M A Silva

7

1 reference

13 November 2017

Edson Amaro-Junior

8

1 reference

13 November 2017

Luiz A F Andrade

9

1 reference

13 November 2017

publication date

22 May 2010

1 reference

13 November 2017

number of pages

5

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

13 November 2017

volume

211

1 reference

13 November 2017

issue

1

1 reference

13 November 2017

page(s)

27-31

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-1867-y

13 November 2017

exact match

0 references

cites work

The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1867-Y

Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke

21 January 2018

1 reference

12 December 2020

Lower dopamine transporter binding potential in striatum during depression

1 reference

12 December 2020

Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging

1 reference

12 December 2020

Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders?

1 reference

12 December 2020

Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

1 reference

12 December 2020

Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease

1 reference

12 December 2020

The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease

1 reference

12 December 2020

In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease

1 reference

12 December 2020

Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease

1 reference

12 December 2020

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

12 December 2020

Striatal dopamine transporter density in major depression

1 reference

12 December 2020

Evaluation of patients with Clinically Unclear Parkinsonian Syndromes submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1.

1 reference

12 December 2020

Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

1 reference

12 December 2020

Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study

1 reference

12 December 2020

Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study

1 reference

12 December 2020

Monoamine transporter availability in Parkinson's disease patients with or without depression

1 reference

12 December 2020

Dopamine transporter binding in depressed patients with anhedonia.

1 reference

12 December 2020

10.1007/S00213-010-1867-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

13 November 2017

1001701635

0 references

1 reference